Free shipping on all orders over $ 500

trans-J-113863 

Cat. No. M56156

All AbMole products are for research use only, cannot be used for human consumption.

trans-J-113863  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

trans-J-113863 is a potent chemokine CCR1 and CCR3 receptor antagonist, and inhibits MIP-1α-induced chemotaxis in CCR1 transfectants and eotaxin-induced chemotaxis in CCR3 transfectants with IC50 of 9.57 and 93.8 nM,respectively.

Chemical Information
Molecular Weight 655.44
Formula C30H37Cl2IN2O2
CAS Number 202796-42-7
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related CCR Products
C-021 dihydrochloride

C-021 dihydrochloride is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 dihydrochloride potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively.

C-021

C-021 is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively.

AZD-5672 

AZD-5672 is an orally active, potent, and selective CCR5 antagonist (IC50=0.32 nM).

MLN3126 

MLN3126 is an orally active and potent CCR9 antagonist.

AZD2423 

AZD2423 is a potent, selective, orally bioavailable, and non-competitive CCR2 chemokine receptor negative allosteric modulator.

  Catalog
Abmole Inhibitor Catalog




Keywords: trans-J-113863  supplier, CCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.